MARINUS PHARMACEUTICALS, INC. Quarterly Interest Expense in USD from Q2 2013 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Marinus Pharmaceuticals, Inc. quarterly/annual Interest Expense history and growth rate from Q2 2013 to Q1 2024.
  • Marinus Pharmaceuticals, Inc. Interest Expense for the quarter ending March 31, 2024 was $4.35M, a 4.8% increase year-over-year.
  • Marinus Pharmaceuticals, Inc. Interest Expense for the twelve months ending March 31, 2024 was $17.1M, a 30.2% increase year-over-year.
  • Marinus Pharmaceuticals, Inc. annual Interest Expense for 2023 was $16.9M, a 58.3% increase from 2022.
  • Marinus Pharmaceuticals, Inc. annual Interest Expense for 2022 was $10.7M, a 313% increase from 2021.
  • Marinus Pharmaceuticals, Inc. annual Interest Expense for 2021 was $2.58M.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $17.1M $4.35M +$199K +4.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $16.9M $4.3M +$608K +16.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-05
Q3 2023 $16.3M $4.24M +$1.61M +61% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $14.7M $4.21M +$1.55M +58.4% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $13.1M $4.15M +$2.46M +145% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $10.7M $3.69M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-05
Q3 2022 $2.63M +$1.96M +288% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $2.66M +$2.31M +657% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $1.69M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q3 2021 $678K Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $351K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q4 2017 $159K $0 -$98K -100% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-12
Q3 2017 $257K $3K -$115K -97.5% Jul 1, 2017 Sep 30, 2017 10-Q 2018-10-29
Q2 2017 $372K $72K -$52K -41.9% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-03
Q1 2017 $424K $84K -$40K -32.3% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-02
Q4 2016 $464K $98K -$23K -19% Oct 1, 2016 Dec 31, 2016 10-K 2019-03-12
Q3 2016 $487K $118K -$3K -2.48% Jul 1, 2016 Sep 30, 2016 10-Q 2017-10-31
Q2 2016 $490K $124K +$7K +5.98% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-01
Q1 2016 $483K $124K +$8K +6.9% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-01
Q4 2015 $475K $121K Oct 1, 2015 Dec 31, 2015 10-K 2018-03-07
Q3 2015 $121K +$92K +317% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-08
Q2 2015 $117K +$88K +303% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $116K Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-02
Q3 2014 $29K Jul 1, 2014 Sep 30, 2014 10-Q 2015-10-29
Q2 2014 $29K -$15.5K -34.8% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-04
Q2 2013 $44.5K Apr 1, 2013 Jun 30, 2013 10-Q/A 2014-10-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.